HealthCare News
Gene May Be New Cancer Treatment TargetInhibiting the gene -- called methylenetetrahydrofolate reductase (MTHFR) -- cut the growth of colon and lung cancer in both laboratory tissue cultures and mice, say researchers at McGill University Health Centre (MUHC), in Montreal. "MTHFR is involved in the synthesis of methionine -- a critical nutrient necessary for the growth of cancer cells. By inhibiting the gene's function, we were able to slow the growth of tumors," principal investigator Rima Rozen, deputy scientific director of the MUHC Research Institute, explained in a prepared statement. The researchers inhibited MTHFR by a relatively new method -- blocking gene activity with a molecule that's the exact opposite, or "antisense," of a tiny section of the MTHFR gene. Read entire article... | 
